ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 01, 2018
- Source ID
- 10.1016/j.vaccine.2018.09.010
Entities
People
- Adam C Soloff
- Amanda C. Larue
- Rebecca A. Stanton
- Rebecca K. Carrell
- Stephen P. Ethier
Organizations
- American Cancer Society
- National Institute of General Medical Sciences
- Susan G. Komen for the Cure
- United States Department of Defense